Document text
Principal Investigator: ANSHU SHRESTHA
Organization: PUBLIC HEALTH INSTITUTE
Fiscal Year: 2024
Award: $244,943
Funding agency: National Cancer Institute
The National Cancer Institute (NCI) Patterns of Care (POC) studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. POC Studies are conducted periodically, typically annually, to satisfy a congressional directive (under Public Law 100-607, Sec. 413 (a)(2)(C) adopted on November 4, 1988) to the NCI to “assess the incorporation of state-of-the-art cancer treatments into clinical practice and the extent to which cancer patients receive such treatments and include the results of such assessment in the biennial reports…”. To satisfy the directive and to update and enhance the utility of the POC Studies, a working group including representatives from the NCI’s Divisions of Cancer Control and Population Sciences and Cancer Treatment and Diagnosis and a representative from the American Cancer Society was developed to review knowledge gaps in cancer therapy dissemination and to develop priority areas for study. The group reached a consensus that a gap remains regarding factors associated with guideline use of biomarker tests and targeted therapy. Furthermore, the group determined there is limited information about the effects of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and receipt of supportive/palliative care among individuals diagnosed with cancer. For feasibility reasons, the group also recommended that this POC Study be focused specifically on the patterns of care for patients newly diagnosed with prostate or ovarian cancer. This POC Study will also collect data on documentation of palliative care and patient financial impacts of the COVID-19 pandemic. Relevant information on cancer diagnosis, cancer recurrence and metastasis, patterns of care (e.g., utilization of biomarker testing, specific cancer treatments, supportive/palliative care), and patient financial stability shall be abstracted from medical records among patients aged 20 years of older who were diagnosed with prostate or ovarian cancer in 2021.
Terms: <20 year old><20 years of age><Adjuvant Therapy><Adopted><Affect><Age><American Cancer Society><Area><Beds><Biological Markers><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 pandemic affected><COVID-19 pandemic consequence><COVID-19 pandemic effects><COVID-19 pandemic impact><COVID-19 pandemic impacted><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Cancer Patient><Cancer Treatment><Cancers><Characteristics><Communities><Congresses><Consensus><DCCPS><Data><Diagnosis><Diagnostic tests><Division of Cancer Control and Population Sciences><Documentation><Educational process of instructing><Endocrine Therapy><Ethnic Origin><Ethnicity><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><Guidelines><Health Care Systems><Healthcare Systems><Hormonal Therapy><Hospitals><Immune mediated therapy><Immunologically Directed Therapy><Immunotherapy><Incidence><Individual><Inpatients><Insurance Coverage><Insurance Status><Knowledge><Laws><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Ovarian Neoplasm><Malignant Ovarian Tumor><Malignant Tumor><Malignant Tumor of the Ovary><Malignant Tumor of the Prostate><Malignant neoplasm of ovary><Malignant neoplasm of prostate><Malignant prostatic tumor><Medical><Medical Records><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><NCI Organization><National Cancer Institute><Neoplasm Metastasis><Newly Diagnosed><Operative Procedures><Operative Surgical Procedures><Out-patients><Outpatients><Ovary Cancer><Palliative Care><Palliative Therapy><Palliative Treatment><Patient Care><Patient Care Delivery><Patients><Pattern><Patterns of Care><Physicians><Physicians' Offices><Prostate CA><Prostate Cancer><Prostate malignancy><Prostatic Cancer><Race><Races><Radiation therapy><Radiotherapeutics><Radiotherapy><Recommendation><Records><Recurrent Malignant Neoplasm><Recurrent Malignant Tumor><Reporting><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SYS-TX><Screening for cancer><Secondary Neoplasm><Secondary Tumor><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Surgical><Surgical Interventions><Surgical Procedure><Systemic Therapy><Teaching><Testing><Time><United States><Update><adjuvant treatment><age 20 years><ages><anti-cancer therapy><bio-markers><biologic marker><biomarker><cancer care><cancer diagnosis><cancer metastasis><cancer recurrence><cancer therapy><cancer-directed therapy><care for patients><care of patients><caring for patients><chemotherapy><clinical practice><co-morbid><co-morbidity><comfort care><comorbidity><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 pandemic consequence><coronavirus disease 2019 pandemic impact><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><early cancer detection><effects following the COVID-19 pandemic><geographic site><hormone therapy><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><impact of the SARS-CoV-2 pandemic><malignancy><neoplasm/cancer><ovarian cancer><pandemic concern><pandemic potential><pandemic risk><pandemic threat><racial><racial background><racial origin><radiation treatment><screening cancer patients><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><surgery><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><treatment pattern><treatment with radiation><tumor cell metastasis><twenty year old><twenty years of age><work group><working group>